Human Genetics

, Volume 115, Issue 3, pp 208–212 | Cite as

A resistin gene polymorphism is associated with body mass index in women

  • Vanessa S. Mattevi
  • Verônica M. Zembrzuski
  • Mara H. Hutz
Original Investigation
First Online:
Received:
Accepted:

Abstract

The potential association of resistin (RETN) gene variability with obesity-related phenotypes was investigated in 585 non-diabetic individuals of European descent. The polymorphism studied (−420 C>G) is located in the RETN gene 5′-flanking region. A significant association between the polymorphism and body mass index and waist circumference was observed in the women subsample (n=356), where the G allele was somewhat less frequent in the overweight/obese group than in normal-weight individuals (0.25 vs. 0.32; p=0.040; OR=0.70 [0.50–0.98]). Female carriers of the G-allele presented a lower mean BMI than C/C homozygotes (25.5 vs. 26.8 kg/m2; p=0.010). Furthermore, when women were stratified by menopausal status, the association was restricted to premenopausal women (C/C homozygotes, mean BMI=26.3 kg/m2; G-carriers, 24.4 kg/m2; p=0.014). Our findings suggest that RETN gene variation has gender-specific effects on BMI and warrants further investigation of its implications for the development of obesity.

Keywords

Waist Circumference European Descent Resistin Level Serum Resistin Level Resistin mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Acknowledgements

Thanks are due to Ana Lúcia S. Antunes and Maria Perpetua de Oliveira Pinto from the Clinical Analysis Laboratory of the Pharmacy College of Federal University of Rio Grande do Sul and to Fabiana M. de Andrade, Marilu Fiegenbaum, Silvana de Almeida and Marcel Arsand for help in the sample collection. Financial support was provided by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, Brazil), Programa de Apoio a Núcleos de Excelência (PRONEX, Brazil) and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS, Brazil).

References

  1. Abramson JH, Gahlinger PM (2001) Computer programs for epidemiologists: PEPI version 4.0. Sagelbrush Press, Salt Lake CityGoogle Scholar
  2. Chagnon YC, Rankinen T, Snyder EE, Weisnagel SJ, Pérusse L, Bouchard C (2003) The human obesity gene map: the 2002 update. Obes Res 11:313–367PubMedGoogle Scholar
  3. Engert JC, Vohl M-C, Williams SM, Lepage P, Loredo-Osti JC, Faith J, Doré C, Renaud Y, Burtt NP, Villeneuve A, Hirschhorn JN, Altshuler D, Groop LC, Després J-P, Gaudet D, Hudson TJ (2002) 5′flanking variants of resistin are associated with obesity. Diabetes 51:1629–1634PubMedGoogle Scholar
  4. Hofbauer KG (2002) Molecular pathways to obesity. Int J Obes Relat Metab Disord 26 (Suppl 2):S18–S27CrossRefGoogle Scholar
  5. Kim K-H, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252–11256CrossRefPubMedGoogle Scholar
  6. Ma X, Warram JH, Trischitta V, Doria A (2002) Genetic variants at the resistin locus and risk of type 2 diabetes in caucasians. J Clin Endocrinol Metab 87:4407–4410CrossRefPubMedGoogle Scholar
  7. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S (2002) Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:247–2410Google Scholar
  8. Nogueiras R, Gualillo O, Caminos JE, Casanueva FF, Diéguez C (2003) Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes Res 11:408–414PubMedGoogle Scholar
  9. Osawa H, Onuma H, Murakami A, Ochi M, Nishimiya T, Kato K, Shimizu I, Fujii Y, Ohashi J, Makino H (2002) Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 51:863–866PubMedGoogle Scholar
  10. Pizzuti A, Argiolas A, Di Paola R, Baratta R, Rauseo A, Bozzali M, Vigneri R, Dallapiccola B, Trischitta V, Frittitta L (2002) An ATG repeat in the 3′-untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 87:4403–4406CrossRefPubMedGoogle Scholar
  11. Rosenbaum M, Leibel RL (1999) Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin. J Clin Endocrinol Metab 84:1784–1789CrossRefPubMedGoogle Scholar
  12. Salzano FM, Bortolini MC (2002) The evolution and genetics of Latin American populations. Cambridge University Press, CambridgeGoogle Scholar
  13. Salzano FM, Freire-Maia N (1970) Problems in human biology. A study of Brazilian populations. Wayne State University Press, DetroitGoogle Scholar
  14. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O’Rahilly S (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50:2199–2202PubMedGoogle Scholar
  15. Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, Di Mario U, Baroni MG (2002) Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes 51:860–862PubMedGoogle Scholar
  16. Smith SR, Bai F, Charbonneau C, Janderová L, Argyropoulos G (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611–1618PubMedGoogle Scholar
  17. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312CrossRefPubMedGoogle Scholar
  18. Tan M-S, Chang S-Y, Chang D-M, Tsai JC-R, Lee Y-J (2003) Association of resistin gene 3′-untranslated region +62G→ A polymorphism with type 2 diabetes and hypertension in a Chinese population. J Clin Endocrinol Metab 88:1258–1263CrossRefPubMedGoogle Scholar
  19. Tchernof A (2003) Regional fat distribution and menopause. In: Medeiros-Neto G, Halpern A, Bouchard C (eds) Progress in obesity research: 9. Proceedings of the 9th international congress on obesity, São Paulo 2002. John Libbey Eurotext, Paris, pp 693–696Google Scholar
  20. Ukkola O (2002) Resistin—a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol 147:571–574PubMedGoogle Scholar
  21. Urbanek M, Du Y, Silander K, Collins FS, Steppan CM, Strauss JF, Dunaif A, Spielman RS, Legro RS (2003) Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes 52:214–217PubMedGoogle Scholar
  22. Wang H, Chu WS, Hemphill C, Elbein SC (2002) Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:2520–2524PubMedGoogle Scholar
  23. Yannakoulia M, Yiannakouris N, Blüher S, Matalas A-L, Klimis-Zacas D, Mantzoros CS (2003) Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J Clin Endocrinol Metab 88:1730–1736CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Vanessa S. Mattevi
    • 1
  • Verônica M. Zembrzuski
    • 1
  • Mara H. Hutz
    • 1
  1. 1.Departamento de Genética, Instituto de BiociênciasUniversidade Federal de Rio Grande do SulPorto AlegreBrazil

Personalised recommendations